Short-term results of continuous venovenous haemodiafiltration versus peritoneal dialysis in 40 neonates with inborn errors of metabolism
- PMID: 30895385
- DOI: 10.1007/s00431-019-03361-4
Short-term results of continuous venovenous haemodiafiltration versus peritoneal dialysis in 40 neonates with inborn errors of metabolism
Abstract
Several recent studies have reported that toxic metabolites accumulated in the body as a product of inborn errors of metabolism (IEM) are eliminated more rapidly with continuous venovenous hemodiafiltration (CVVHDF) than with peritoneal dialysis (PD). However, there is still uncertainty about the impacts of dialysis modalities on the short-term outcome. Here, it was aimed to investigate the effects of dialysis modalities on the short-term outcome. This retrospective study included 40 newborn infants who underwent PD (29 patients) or CVVHDF (11 patients) due to inborn errors of metabolism at a tertiary centre, between June 2013 and March 2018. The outcomes and the potential effects of the dialysis modality were evaluated. Of 40 patients, 21 were urea cycle defect, 14 were organic academia, and 5 were maple syrup urine disease. The median 50% reduction time of toxic metabolites were shorter in patients treated with CVVHDF (p < 0.05). Catheter blockage was the most common complication observed in PD group (24.1%), whereas in CVVHDF group hypotension and filter blockage were more common. There was no significant difference in mortality between dialysis groups (38% vs. 45.4%, p > 0.05). In patients with hyperammonaemia, duration of plasma ammonia > 200 μg/dL was the most important factor influencing mortality (OR 1.05, CI 1.01-1.09, p = 0.007).Conclusion: This study showed that CVVHDF is more efficient than PD to rapidly eliminate toxic metabolites caused by IEM in newborn infants, but not in improving survival. What is Known: •Toxic metabolites are eliminated more rapidly with CVVHDF than with PD. •Higher complication rates were reported with rigid peritoneal catheters in PD and catheter blockage in CVVHDF. What is New: •Prolonged duration of plasma ammonia levels above a safe limit (200 μg/dL) was associated with increased mortality. •Lower catheter-related complication rates may have been associated with the use of Tenckhoff catheters in PD and the use of right internal jugular vein in CVVHDF.
Keywords: Continuous venovenous hemodiafiltration; Inborn errors of metabolism; Newborn; Peritoneal dialysis.
Similar articles
-
Continuous venovenous hemodiafiltration in the treatment of newborns with an inborn metabolic disease: a single center experience.Turk J Med Sci. 2020 Feb 13;50(1):12-17. doi: 10.3906/sag-1811-8. Turk J Med Sci. 2020. PMID: 31014046 Free PMC article.
-
Continuous veno-venous hemodiafiltration in neonates with maple syrup urine disease.Ther Apher Dial. 2022 Jun;26(3):658-666. doi: 10.1111/1744-9987.13816. Epub 2022 Feb 24. Ther Apher Dial. 2022. PMID: 35166449
-
Efficacy of peritoneal dialysis in neonates presenting with hyperammonaemia due to urea cycle defects and organic acidaemia.Nephrology (Carlton). 2019 Mar;24(3):330-335. doi: 10.1111/nep.13224. Nephrology (Carlton). 2019. PMID: 29356227
-
Experience with continuous venovenous hemodiafiltration in four newborns: A case series and review of the literature.Hemodial Int. 2015 Oct;19(4):E59-62. doi: 10.1111/hdi.12234. Epub 2014 Oct 20. Hemodial Int. 2015. PMID: 25330394 Review.
-
[Continuous venovenous hemodiafiltration in critically ill patients with acute renal failure].Ugeskr Laeger. 2000 May 15;162(20):2868-71. Ugeskr Laeger. 2000. PMID: 10860424 Review. Danish.
Cited by
-
The Efficacy and Outcomes of Renal Replacement Therapy in Pediatric Metabolic Disorders.J Clin Med. 2024 Oct 28;13(21):6452. doi: 10.3390/jcm13216452. J Clin Med. 2024. PMID: 39518591 Free PMC article.
-
Factors associated with poor outcomes in patients with maple syrup urine disease in a tertiary government hospital: A retrospective cohort study.JIMD Rep. 2024 Nov 17;66(1):e12458. doi: 10.1002/jmd2.12458. eCollection 2025 Jan. JIMD Rep. 2024. PMID: 39723125 Free PMC article.
-
CARPEDIEM® for continuous kidney replacement therapy in neonates and small infants: a French multicenter retrospective study.Pediatr Nephrol. 2023 Aug;38(8):2827-2837. doi: 10.1007/s00467-022-05871-0. Epub 2023 Jan 10. Pediatr Nephrol. 2023. PMID: 36625933
-
Real-life effects, complications, and outcomes in 39 critically ill neonates receiving continuous kidney replacement therapy.Pediatr Nephrol. 2023 Sep;38(9):3145-3152. doi: 10.1007/s00467-023-05944-8. Epub 2023 Mar 29. Pediatr Nephrol. 2023. PMID: 36988692
-
Inborn errors of metabolism in neonates and pediatrics on varying dialysis modalities: a systematic review and meta-analysis.Pediatr Nephrol. 2025 Jul;40(7):2177-2188. doi: 10.1007/s00467-024-06547-7. Epub 2024 Nov 11. Pediatr Nephrol. 2025. PMID: 39523291 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical